Pulmuone, AgentAI and EOFlow Raise a Combined 72.4 Billion Won in Same-Day Private Placements

Three companies listed in Seoul — KOSPI-traded food group Pulmuone and KOSDAQ-listed AgentAI and EOFlow — disclosed board decisions on July 29 to raise a combined 72.4 billion won through third-party allotment share issues. Pulmuone’s 40 billion won placement is aimed at repaying debt, AgentAI’s 6.5 billion won raise funds day-to-day operations and accompanies a change-of-control agreement, and EOFlow is bringing in 25.9 billion won from a designated investor.

Pulmuone Leans on New Equity to Pay Down Debt

The largest of the three placements belongs to Pulmuone, which said it will issue roughly 40 billion won of new shares to a designated investor, with the proceeds earmarked primarily for debt repayment. The company filed the capital increase with the Financial Supervisory Service’s electronic disclosure system alongside a separate filing covering the issuance of debt securities that qualify as equity capital — an instrument companies typically use to strengthen capital ratios without immediate shareholder dilution beyond the placement itself.

The dual filing suggests a broader balance-sheet repair effort rather than a one-off funding round. Pulmuone, founded in 1981 and headquartered in Seoul, built its name on tofu and other plant-based staples, and its U.S. subsidiary holds roughly three-quarters of the American tofu market. That overseas expansion — including the 2016 acquisition of Vitasoy’s U.S. arm and its Nasoya tofu brand — has been a growth engine, but growth funded partly with borrowings is now being refinanced through equity and equity-like capital.

At AgentAI, Fresh Capital Arrives With New Control

AgentAI’s placement is the smallest in won terms but arguably the most consequential for its shareholders. The KOSDAQ-listed company said it will raise about 6.5 billion won by issuing new shares to an investment partnership named Prime Value, citing operating funds among the uses of proceeds. On the same day, the company filed a disclosure covering a contract concerning a change in management control — the kind of filing that accompanies the handover of a controlling stake.

Taken together, the two filings indicate the placement is not merely a funding exercise: the incoming investor is positioned to become a new anchor shareholder. For a small-cap issuer, pairing a capital injection with a control agreement is a common route for a struggling or pivoting company to secure both cash and new management direction in a single transaction.

EOFlow Adds 25.9 Billion Won From a Designated Investor

EOFlow, also listed on the KOSDAQ, decided on a 25.9 billion won third-party allotment, with the new shares going to an investor identified in the disclosure as IPV. The company did not attach the placement to a control-change filing, and the disclosed terms center on the size of the raise and the designated subscriber.

The Appeal — and the Cost — of Third-Party Allotments

The clustering of three such decisions on a single trading day illustrates why this structure dominates Korean corporate fundraising at the smaller end of the market. A third-party allotment lets a board place shares directly with a chosen investor, avoiding the longer subscription process of a rights offering and eliminating the risk that a public offering goes undersubscribed. The trade-off falls on existing shareholders, who are diluted without the option to participate.

The same mechanism also serves as Korea’s standard vehicle for control transactions, as AgentAI’s case shows: issuing new shares to an incoming owner injects cash into the company itself, unlike a secondary block sale where proceeds go to the departing shareholder. Separately, Davolink reported the results of its own completed third-party placement the same day, adding to the run of placement-related filings. For investors in KOSDAQ names especially, the key detail to check in each disclosure is not the headline amount but who the designated subscriber is — and whether a control agreement is filed alongside.